Fmr LLC Alkermes Plc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Fmr LLC holds 1,278,006 shares of ALKS stock, worth $41.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,278,006

Previous 1,543,058 17.18%

Holding current value

$41.1 Million

Previous $51 Million 28.24%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$26.59 - $32.65 $7.05 Million - $8.65 Million	-265,052 Reduced 17.18%	1,278,006 $36.6 Million
Q1 2025 May 12, 2025	BUY	$28.08 - $36.0 $37.3 Million - $47.9 Million	1,329,485 Added 622.5%	1,543,058 $51 Million
Q4 2024 Feb 13, 2025	SELL	$25.7 - $31.46 $3.42 Million - $4.19 Million	-133,153 Reduced 38.4%	213,573 $6.14 Million
Q3 2024 Nov 13, 2024	SELL	$23.01 - $28.55 $6.05 Million - $7.51 Million	-263,115 Reduced 43.14%	346,726 $9.7 Million
Q2 2024 Aug 13, 2024	BUY	$23.21 - $27.24 $11.7 Million - $13.8 Million	505,204 Added 482.82%	609,841 $14.7 Million
Q1 2024 May 13, 2024	SELL	$26.4 - $32.56 $25 Million - $30.9 Million	-948,583 Reduced 90.07%	104,637 $2.83 Million
Q4 2023 Feb 13, 2024	SELL	$23.37 - $28.68 $6.02 Million - $7.39 Million	-257,789 Reduced 19.66%	1,053,220 $29.2 Million
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $1.16 Million - $1.37 Million	42,748 Added 3.37%	1,311,009 $36.7 Million
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $5.69 Million - $6.75 Million	200,608 Added 18.79%	1,268,261 $39.7 Million
Q1 2023 May 11, 2023	BUY	$25.31 - $29.02 $10.1 Million - $11.6 Million	399,015 Added 59.68%	1,067,653 $30.1 Million
Q4 2022 Feb 13, 2023	SELL	$21.94 - $26.24 $7.36 Million - $8.8 Million	-335,283 Reduced 33.4%	668,638 $17.5 Million
Q3 2022 Nov 10, 2022	SELL	$22.0 - $31.87 $1.51 Million - $2.19 Million	-68,802 Reduced 6.41%	1,003,921 $22.4 Million
Q2 2022 Aug 12, 2022	BUY	$26.4 - $30.54 $21.8 Million - $25.2 Million	826,648 Added 335.93%	1,072,723 $32 Million
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $5.11 Million - $6.2 Million	221,435 Added 898.68%	246,075 $6.47 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $528,934 - $790,322	24,636 Added 615900.0%	24,640 $573,000
Q2 2021 Aug 13, 2021	BUY	$18.78 - $25.15 $75 - $100	4 New	4 $0

Others Institutions Holding ALKS

# of Institutions

392

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.28B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account